title: Tacrine may alter APP-like protein levels in the lumbar CSF of Alzheimer patients.
authors.forename: N A
authors.initials: NA
authors.lastname: Clarke
authors.forename: H
authors.initials: H
authors.lastname: Soininen
authors.forename: L
authors.initials: L
authors.lastname: Gustafson
authors.forename: L
authors.initials: L
authors.lastname: Minthon
authors.forename: K
authors.initials: K
authors.lastname: Alhainen
authors.forename: P T
authors.initials: PT
authors.lastname: Francis
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000503:physiopathology*; D016564:Amyloid beta-Protein Precursor / Q000031:analogs & derivatives* / Q000134:cerebrospinal fluid* / Q000378:metabolism; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013619:Tacrine / Q000494:pharmacology*
chemical_list: C489697:APLP1 protein, human; D016564:Amyloid beta-Protein Precursor; D002800:Cholinesterase Inhibitors; D013619:Tacrine